Solid Biosciences Inc. (27)
Browse by Contract Category
Contracts
-
Registration Rights Agreement, dated December 10, 2020, by and among the Company and the other parties thereto
(Filed With SEC on December 11, 2020)
-
First Amendment, dated as of October 9, 2020, to the Exclusive Patent License by and between the Company and the University of Washington
(Filed With SEC on November 5, 2020)
-
Investor Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc
(Filed With SEC on November 5, 2020)
-
Collaboration and License Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc
(Filed With SEC on November 5, 2020)
-
Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan
(Filed With SEC on August 6, 2020)
-
Securities Purchase Agreement, dated December 10, 2020, by and among the Company and the other parties thereto
(Filed With SEC on December 11, 2020)
-
Stock Purchase Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc
(Filed With SEC on November 5, 2020)
-
Form of Stock Option Agreement under the 2020 Equity Incentive Plan
(Filed With SEC on August 6, 2020)
-
Consulting Agreement, dated as of June 16, 2020, by and between Solid Biosciences Inc. and Ian F. Smith
(Filed With SEC on August 6, 2020)
-
Summary of Non-Employee Director Compensation Program
(Filed With SEC on August 6, 2020)
-
Consulting Agreement, dated as of February 1, 2020, by and between Solid Biosciences Inc. and Ian F. Smith
(Filed With SEC on May 7, 2020)
-
Summary of Non-Employee Director Compensation Program
(Filed With SEC on May 7, 2020)
-
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Jorge Quiroz
(Filed With SEC on March 12, 2020)
-
Consulting Agreement, dated as of January 15, 2020 by and between Solid Biosciences Inc. and Jorge Quiroz
(Filed With SEC on March 12, 2020)
-
Consulting Agreement, dated as of January 15, 2020, by and between Solid Biosciences Inc. and Alvaro Amorrortu
(Filed With SEC on March 12, 2020)
-
Consulting Agreement, dated as of January 1, 2020, by and between Solid Biosciences Inc. and Andrey Zarur
(Filed With SEC on March 12, 2020)
-
Description of the Companys Securities Registered under Section 12 of the Exchange Act
(Filed With SEC on March 12, 2020)
-
Registration Rights Agreement, dated July 25, 2019, by and among the Company and the other parties thereto
(Filed With SEC on July 26, 2019)
-
Form of Pre-Funded Warrant to Purchase Common Stock to be issued pursuant to the Securities Purchase Agreement
(Filed With SEC on July 26, 2019)
-
Securities Purchase Agreement, dated July 25, 2019, by and among the Company and the other parties thereto
(Filed With SEC on July 26, 2019)
-
Consulting Agreement, dated as of January 1, 2019, by and between Solid Biosciences Inc. and Andrey Zarur
(Filed With SEC on May 13, 2019)
-
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Alvaro Amorrortu
(Filed With SEC on March 13, 2019)
-
Summary of Non-Employee Director Compensation Program
(Filed With SEC on March 13, 2019)
-
Form of Nonqualified Stock Option Agreement under 2018 Omnibus Incentive Plan
(Filed With SEC on March 13, 2019)
-
Form of Incentive Stock Option Agreement under 2018 Omnibus Incentive Plan
(Filed With SEC on March 13, 2019)
-
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Carl Morris. Ph.D
(Filed With SEC on March 13, 2019)
-
Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Ilan Ganot
(Filed With SEC on March 13, 2019)